欢迎来到西安迈博睿(Mabioway)生物科技有限公司 Call: 15339069646 | E-mail: info@mabioway.cn 在线留言 |

服务热线

15339069646
网站导航
当前位置: 首页 > 产品展示 > 抗体产品 > 一抗 > 其他抗体
其他抗体

Anti-CD7 mAbs

简要描述:

This antibody binds the extracellular domain of human CD7. CD7 is expressed on the majority of immature and mature T-lymphocytes, and T cell leukemia. It is also found on natural killer cells, a small subpopulation of normal B cells and on malignant B cells. CD7 is useful in the identification of precursor T cells as well as an important marker for the identification of leukemic T cells.

产品参数:

Cat. No.:MABL-1078

Species:Engineer

Species Reactivity:Human

Type:Recombinate

Application:block, FC

详细介绍

Key features and details


Cat. No.

MABL-1078

Name

Anti-CD7 mAbs

Clone No.

AFD- TH69

From

Recombinant Antibody

Isotype

Engineer antibody

Application

block;, FC

Species Reactivity

Human

Basic Information


Specificity

This antibody binds the   extracellular domain of human CD7. CD7 is expressed on the majority of   immature and mature T-lymphocytes, and T cell leukemia. It is also found on   natural killer cells, a small subpopulation of normal B cells and on   malignant B cells. CD7 is useful in the identification of precursor T cells   as well as an important marker for the identification of leukemic T cells.

Alternative Name

GP40; TP41; T-cell antigen CD7; T-cell leukemia antigen; T-cell surface antigen Leu-9; TH-69

UniProt

P09564

Immunogen


Application Notes

The therapeutic application of this antibody   was explored to determine its potential use in the treatment of Human T-cell   acute lymphocytic leukemia (ALL). When nude mice bearing approx. 2 g of tumor   were treated with a single injection of CD7 antibody TH-69, 82.6% reached   complete remission within 10 d whereas 13.0% showed partial remission. (PMID:   8904888). This antibody was also used in the development of a recombinant   immunotoxin by linking the scFv version of this antibody to a truncated   Pseudomonas exotoxin A fragment containing the catalytic domains II and III   but lacking the receptor binding domain I. Approximately 20% of leukemic   cells from a patient with CD7-positive acute T-cell leukemia kept in   long-term primary culture for 30 cell generations were killed within 96 h   after treatment with the toxin (PMID: 12019163). This antibody was also used   in the generation of a fusion protein scFvCD7:sFasL, that is designed to have   leukemia-restricted activity. wherein the scFv version of this antibody is   genetically linked to soluble homotrimeric FasL. 

Antibody First Published

Gramatzki et al. Monoclonal antibodies   developed for diagnosis of T cell and very immature leukemias. Blut, 50   (1985), p. 216.

Note on publication


COA Information For reference only, actual COA shall prevail

Size

100 μg Purified antibody.

Concentration

1 mg/ml.

Purification

Protein A affinity purified

Buffer

PBS with 0.02% Proclin 300.

Concentration

1 mg/ml.

Storage Recommendation

Store at 4⁰C for up to 3 months. For   longer storage, aliquot and store at - 20⁰C.


 


服务咨询

留言框

  • 标题:

  • 留言内容:

  • 您的单位:

  • 您的姓名:

  • 联系电话:

  • 常用邮箱:

  • 详细地址:

上一篇: Anti-CD7 mAbs

下一篇: Anti-CD7 mAbs

推荐产品

联系我们

Copyright © 2012-2029 西安迈博睿(Mabioway)生物科技有限公司 版权所有

地址:陕西省西安市浐灞生态区广运潭大道南段4555号长安大学科技园4号楼A单元2层

电话:15339069646 邮箱:info@mabioway.cn

陕ICP备2021006339号